To defend its position in the anti-obesity market, Novo Nordisk has responded on multiple fronts, cutting prices on existing Wegovy doses in India by up to 37% in November 2025, partnering with Emcure to bring another semaglutide brand to the Indian market, and now moving to a higher-dose formulation that generics cannot replicate immediately
Anything we place in the human body can carry risk, including those things which are thought to be natural, such as vitamins or fluids, says Brent A
In the United States, approximately 1 in 8 adults now use GLP-1 medications, making access and prescriber expertise increasingly important for safe, effective treatment
The production of ROS and free radicals exacerbates inflammation and hyperplasia of keratinocyte cells [8]
Is the Viso 2 Pro Red Light safe for the scalp
Mme lorsque les chiffres defficacit sont impressionnants, la russite dpend de trois points : Une indication bien pose IMC, comorbidits (apne du sommeil, HTA, diabte, dyslipidmie, statose hpatique), traitements en cours, histoire pondrale, risques